Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Use of Activated Carbon in Recovery Process – V 2.0

Posted on By

API Manufacturing: SOP for Use of Activated Carbon in Recovery Process – V 2.0

Standard Operating Procedure for Use of Activated Carbon in Recovery Process in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/051/2025
Supersedes SOP/API/051/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To establish a standardized procedure for the use of activated carbon during the recovery of solvents in API manufacturing, ensuring the removal of organic impurities, color bodies, and odor-causing compounds, while maintaining product integrity and GMP compliance.

2. Scope

This SOP applies to all solvent recovery processes where activated carbon is used to treat contaminated or discolored solvents before distillation or reuse within the API manufacturing unit.

See also  API Manufacturing: SOP for Safety Measures in Solvent Recovery Operations - V 2.0

3. Responsibilities

  • Production Operator: Handle and dose activated carbon as per batch instructions.
  • Shift Supervisor: Monitor carbon treatment parameters and document usage.
  • QA Department: Approve carbon usage and review records for compliance.
  • QC Department: Perform quality testing of solvents post carbon treatment.

4. Accountability

The Production Manager is accountable for execution of this procedure. QA Manager is accountable for ensuring adherence to quality and regulatory guidelines.

5. Procedure

5.1 Selection and Verification

  1. Use only pharmaceutical-grade activated carbon approved by QC.
  2. Check for:
    • Certificate of Analysis (CoA)
    • Mesh size and adsorption efficiency
    • Expiry date and batch number

5.2 Charging Activated Carbon

  1. Ensure solvent holding tank or treatment vessel is clean and dry.
  2. Calculate required quantity of activated carbon based on:
    • Solvent type and volume
    • Contamination level (typically 0.2–1.0% w/v)
  3. Slowly add activated carbon under stirring using PPE and dust mask to avoid inhalation.
  4. Maintain agitation for 30 to 90 minutes depending on the impurity profile.
See also  API Manufacturing: SOP for Collection and Segregation of Used Solvents - V 2.0

5.3 Filtration and Collection

  1. After treatment, filter the carbon-treated solvent through sparkler or Nutsche filter.
  2. Ensure no carbon particles remain in the filtrate. Refilter if required.
  3. Collect treated solvent in a clean, labeled container for further distillation or reuse.

5.4 Documentation and Control

  1. Record:
    • Batch number
    • Solvent name and volume
    • Carbon quantity used
    • Contact time

    in the “Activated Carbon Usage Log” (Annexure-1).

  2. Attach CoA copy of activated carbon to batch documentation.
  3. QC to perform post-treatment testing (color, purity, odor) and release for reuse.

5.5 Disposal

  1. Used carbon is hazardous waste and must be transferred to EHS-approved bins.
  2. Dispose through CPCB-approved hazardous waste handlers with manifest records (refer SOP/API/049/2025).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QC: Quality Control
  • QA: Quality Assurance
  • CoA: Certificate of Analysis
  • PPE: Personal Protective Equipment

7. Documents

  1. Activated Carbon Usage Log (Annexure-1)
  2. CoA of Activated Carbon
  3. QC Test Report of Treated Solvent

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • 21 CFR Part 211 – Subpart D & E
  • WHO TRS 957 – Pharmaceutical Waste Management

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Activated Carbon Usage Log

Date Batch No. Solvent Volume (L) Carbon Used (g) Contact Time (min) Handled By
13/04/2025 API-202504 Toluene 150 300 45

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New Recovery Protocol QA Head
13/04/2025 2.0 Procedure Enhancement and Annexure Added Compliance Update QA Head
See also  API Manufacturing: SOP for Labeling of Raw Materials with Status Tags - V 2.0
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Creams: SOP for Inspecting Sealing Quality in Cream Packaging Machines – V 2.0
Next Post: SOP for Managing Design History Files (DHF)

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version